Content about Acne vulgaris

NEW YORK — Dermatologist Dr. Fredric Brandt is bringing to retail a mattifying version of a coveted formula to market: BB matte.

Developed to treat, protect, mattify, and even skin tone, the all-in-one, oil-free beauty balm is designed to leave oily and acne-prone skin looking fresh and flawless.

HYDERABAD, India — Dr. Reddy's has launched a drug for treating acne, the company said Friday.

The Indian generic drug maker announced the launch of Zenatane (isotretinoin) capsules in the 20-mg and 40-mg strengths. The drug is a therapeutically equivalent generic version of Roche's Accutane. The Food and Drug Administration also approved the drug in the 10-mg strength.

Various versions of the drug had sales of about $309 million during the 12-month period that ended in January, according to IMS Health.

ORCHARD PARK, N.Y. — Oxy is introducing two new lines of products — Oxy Maximum Action and Oxy Daily Defense — that include new packaging to clearly spell out product benefits, active ingredients and recommended usage to consumers.

The January/February 2013 Vitamins & Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Centrum, One-A-Day, NatureMade, VitaFusion, Alive, VirMax-T, MoveFree, Bioglan and Voots products.

Click here for the complete guide.

The November/December 2012 Cough, Cold and Flu Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Mucinex, Vicks, Advil, Theraflu, Delsym, St. Joseph, Hyland's Similasan and Zicam products.

Click here for the complete guide.

With some 40 million to 50 million people in the United States battling acne, it is no surprise that sales of acne treatments continue to be on the rise.

According to data from SymphonyIRI Group, a Chicago-based market research firm, sales of acne treatments rose 0.24% for the 12 weeks ended Oct. 7 at total U.S. multi-outlets, which covers supermarkets, drug stores, mass market retailers (including Walmart), military commissaries, and select club and dollar retail chains.

MONTREAL — Canadian drug maker Valeant Pharmaceuticals International is buying Medicis Pharmaceutical for $2.6 billion, Valeant said Monday.

The $44-per-share deal, which the companies said represents a 39% premium over the closing price of Medicis' shares on Friday, is expected to close in the first half of 2013.

EL SEGUNDO, Calif. — Murad, whose skin care products are available at such retailers as Ulta Beauty and Sephora, has announced the addition of the new Pore & Line Minimizing Hydrator to its Anti-Aging Acne Line, which was created to simultaneously reduce acne and aging concerns.

The July/August 2012 Pain Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Aleve, Advil, Bayer Advanced, Perform, Absorbine, Salonpas, Hyland's Leg Cramps ointment, Arnicare and BenGay Cold Therapy.

Click here for the complete guide.

ALLEGAN, Mich. — The Food and Drug Administration has approved an acne treatment made by Perrigo, the drug maker said Wednesday.

PRINCETON, N.J. — The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said.

Ranbaxy announced the FDA approval of Absorica (isotretinoin), a drug for treating severe recalcitrant nodular acne. The company expects to launch Absorica in the United States in fourth quarter 2012 under an agreement with Canada-based Cipher Pharmaceuticals.

NEW YORK — The Food and Drug Administration has approved a new treatment for acne made by a GlaxoSmithKline subsidiary.

Stiefel announced the approval of Fabior (tazarotene) foam in the 0.1% strength, calling it the only retinoid in a topical foam for treating acne in patients ages 12 years and older.

"Stiefel is dedicated to meeting th needs of patients and dermatologists, and we believe Fabior foam will be an important treatment option for people with moderate-to-severe acne," Stiefel VP North America dermatology Jean-Christophe May said.